Tobacco-specific carcinogenic nitrosamines: Ligands for nicotinic acetylcholine receptors in human lung cancer cells

Biochemical Pharmacology

Volumn 55, Issue 9, 1998, Pages 1377-1384

  Schuller, Hildegard M ^a   Orloff, Michael ^a  

^a Department of Comparative Medicine   (United States)

Author keywords

bungarotoxin; Epibatidine; Nicotinic receptor; Nitrosamine; Tobacco specific

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ALPHA BUNGAROTOXIN; CARCINOGEN; EPIBATIDINE; NICOTINE; NICOTINIC RECEPTOR; NITROSAMINE; NITROSONORNICOTINE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; SMOKING;

ADENOCARCINOMA; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; BUNGAROTOXINS; CARCINOGENS; CARCINOMA, SMALL CELL; CELL DIVISION; HUMANS; KINETICS; LIGANDS; LUNG NEOPLASMS; NITROSAMINES; PLANTS, TOXIC; PYRIDINES; RECEPTORS, NICOTINIC; TOBACCO; TUMOR CELLS, CULTURED;

EID: 0032499397     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00651-5     Document Type: Article

References (28)

1. Weiss W. Epidemiology of lung cancer. Schuller HM. Comparative Respiratory Tract Carcinogensis. 1983;1-18 CRC Press, Boca Raton.
2. Benovitz NL. Nicotine and coronary heart disease. Trends Cardiovasc Med. 1:1991;315-321.
3. Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 9:1990;875-884.
4. Fischer S, Spiegelhalder B, Eisenbarth J, Preussmann R. Investigation on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis. 11:1990;723-730.
5. Hecht SS, Carmella SG, Foiles PG, Murphy SE, Peterson LA. Tobacco-specific nitrosamine adducts. Studies in laboratory animals and humans. Environ Health Perspect. 99:1993;57-63.
6. Armitage AK, Dollery CT, George CF, Houseman TH, Lewis PJ, Turner DM. Absorption and metabolism of nicotine from cigarettes. Br Med J. 4:1975;313-316.
7. Carmella SG, Kagan SS, Kagan M, Foiles PG, Palladino G, Quart AM, Quart E, Hecht SS. Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. Cancer Res. 50:1990;5438-5445.
8. Hecht SS, Trushin N, Reid-Quinn CA, Burak ES, Jones AB, Southers JL, Gombar CT, Carmella SG, Anderson LM, Rice JM. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey Pharmacokinetics and characterization of glucuronide metabolites . Carcinogenesis. 14:1993;229-236.
9. Lindstrom J, Anand R, Peng X, Gerzanich V. Neuronal nicotinic receptor structure and function. Clarke PBS, Quik M, Adlkofer F, Thurau K. Effects of Nicotine on Biological Systems. 1995;45-50 Birkhäuser, Basel.
10. Couturier S, Bertrand D, Matter J-M, Hernandez M-C, Bertrand S, Millar N, Valera S, Barkas T, Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX. Neuron. 5:1990;847-856.
11. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol. 48:1995;280-287.
12. Marks MJ, Burch JB, Collins AC. Effects of chronic nicotine infusion on tolerance development and cholinergic receptors. J Pharmacol Exp Ther. 226:1983;806-816.
13. Schuller HM. Cell type-specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochem Pharmacol. 38:1989;3439-3442.
14. Quik M, Chan J, Patrick J. α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Brain Res. 655:1994;161-167.
15. Schuller HM. Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways. Neurotoxicology. 15:1994;877-886.
16. Codignola A, Tarroni P, Cattaneo MG, Vicentini LM, Clementi F, Sher E. Serotonin release and cell proliferation are under the control of alpha-bungarotoxin-sensitive nicotinic receptors in small cell lung carcinoma cell lines. FEBS Lett. 342:1994;286-290.
17. Schuller HM, Castonguay A, Orloff M, Rossignol G. Modulation of the uptake and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by nicotine in hamster lung. Cancer Res. 51:1991;2009-2014.
18. Hulme EC. Receptor binding studies. Hulme EC. Receptor Biochemistry. 1990;303-315 Oxford University Press, Oxford.
19. McPherson GA. Analysis of radioligand binding experiments A collection of computer programs for the IBM PC . J Phamacol Methods. 14:1985;213-228.
20. 3H](-)nicotine label the same recognition site in rat brain. Mol Pharmacol. 31:1987;169-174.
21. Lambertson CJ. The atmosphere and gas exchange with the lungs and blood. Mountcastle VB. Medical Physiology. Vol. 2:1974;1372-1398 C.V. Mosby Co. Saint Louis.
22. Maneckjee R, Minna JD. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ. 5:1994;1033-1040.
23. 6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumourigenesis in A/J mouse lung. Cancer Res. 51:1991;5557-5564.
24. Hecht SS, Spratt TE, Trushin N. Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Carcinogenesis. 9:1988;161-165.
25. Belinsky SA, Devereux TR, Stoner GD, Anderson MW. Activation of the K-ras protooncogene in lung tumors of mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-butanone (NNK) and nitrosodimethylamine (NDMA). Cancer Res. 49:1988;5303-5311.
26. Reynolds SH, Wiest JS, Devereux TR, Anderson MW, You M. Protooncogene activation in spontaneously occurring and chemically induced rodent and human lung tumors. Klein-Szanto AJP, Anderson MW, Barrett JC, Slaga TJ. Comparative Molecular Carcinogenesis. 1992;303-320 Wiley-Liss, New York.
27. Mitsudomi T, Viallet J, Mulshine JL, Linnoila RI, Minna JD, Gazdar AF. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene. 6:1991;1353-1362.
28. Falzon M, McMahon JB, Gazdar AF, Schuller HM. Preferential metabolism of N-nitrosodiethylamine by two cell lines derived from human pulmonary adenocarcinomas. Carcinogenesis. 7:1986;17-22.